American Society of Hematology

SHERPA: Blue

People

  1. Hamlin
    Hamlin
  2. Horwitz
    Horwitz
  3. Noy
    Noy
  4. Zelenetz
    Zelenetz
  5. Palomba
    Palomba
  6. Dickson
    Dickson
  7. Markowitz
    Markowitz
  8. Moskowitz
    Moskowitz
  9. Papanicolaou
    Papanicolaou
  10. Sarasohn
    Sarasohn

Groups

  1. Center for Hematologic Malignancies (5)
  2. Department of Medicine (5)
  3. Hematologic Malignancies, Division of (5)
  4. Lymphoma (5)
  5. Population Sciences Research Program (4)
  6. Nursing (3)
  7. Radiology, Department of (2)
  8. Survivorship Research (2)
  9. Biostatistics Service (1)
  10. Body Imaging Service (1)
Search Within
  1. "2006"
  2. "Carol Portlock"
Formats
  1. Meeting Abstract (5)
Groups
  1. Center for Hematologic Malignancies (5)
  2. Department of Medicine (5)
  3. Hematologic Malignancies, Division of (5)
  4. Lymphoma (5)
  5. Population Sciences Research Program (4)
  6. Nursing (3)

More Groups

People
  1. Carol Portlock (5)
  2. Paul Hamlin (5)
  3. Andrew Zelenetz (4)
  4. Ariela Noy (4)
  5. Craig Moskowitz (4)
  6. Steven Horwitz (4)

More People

Years
  1. 2006 (5)
Publications
  1. Blood (5)

Results (5)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Infectious disease associations in advanced stage, indolent lymphoma (Follicular, FL and non-follicular, nFL): Developing a lymphoma prevention strategy
    Meeting Abstract

    Portlock, C. S.; Hamlin, P. A.; Noy, A.; Palomba, M. L.; Rosenzweig, L.; Walker, D.; Corcoran, S.; Chey, W. D.; Gaydos, C. A.; Schwartz, I.; more...
    Blood (2006)

    Fulltext@MSK | Save
  • Pralatrexate (PDX) produces durable complete remissions in patients with chemotherapy resistant precursor and peripheral T-Cell lymphomas: Results of the MSKCC phase I/II experience
    Meeting Abstract

    O'Connor, O. A.; Hamlin, P. A.; Gerecitano, J.; Portlock, C. S.; Noy, A.; Moskowitz, C.; Straus, D. J.; Sarasohn, D.; Dumitrescu, O.; Pappanicholaou, J.; more...
    Blood (2006)

    Fulltext@MSK | Save
  • Phase II trial of dose-dense R-CHOP followed by risk-adapted consolidation with either ICE or ICE and ASCT, based upon the results of biopsy confirmed abnormal interim restaging PET scan, improves outcome in patients with advanced stage DLBCL
    Meeting Abstract

    Moskowitz, C.; Hamlin, P. A.; Horwitz, S. M.; Noy, A.; O'Connor, O. A.; Palomba, M. L.; Portlock, C. S.; Straus, D. J.; Lessac-Chenen, S.; Weaver, A.; more...
    Blood (2006)

    Fulltext@MSK | Save
  • Relapsed and refractory primary mediastinal diffuse large B-cell lymphoma: Outcome with ICE-based treatment
    Meeting Abstract

    Hamlin, P. A.; Dickson, M.; Kewalramani, T.; Horwitz, S. M.; Portlock, C. S.; Yahalom, J.; Zelenetz, A. D.; Moskowitz, C. H.
    Blood (2006)

    Fulltext@MSK | Save
  • The schedule dependent combination of bortezomib (Bor) with rituximab (R), cyclophosphamide (C) and prednisone (P) produces minimal toxicity, even at relatively high doses of proteasome inhibitor, in patients with relapsed/refractory indolent B-cell lymphomproliferative disorders
    Meeting Abstract

    Gerecitano, J.; Portlock, C.; Noy, A.; Hamlin, P.; Moskowitz, C.; Straus, D.; Horwitz, S. M.; Palomba, M. L.; Dumitrescu, O. L.; Pappanicholaou, J.; more...
    Blood (2006)

    Fulltext@MSK | Save